Peter Göttle - Search Results

Year	Number of Results
2008	1
2009	1
2010	1
2012	1
2013	1
2014	1
2015	3
2016	2
2017	1
2018	3
2019	9
2020	2
2021	4
2022	4
2023	2
2024	1

1

There is more than one route to achieve myelin repair.

Göttle P, Tsigaras T, Küry P. Göttle P, et al. Regen Med. 2022 Oct;17(10):699-703. doi: 10.2217/rme-2022-0089. Epub 2022 Jul 11. Regen Med. 2022. PMID: 35815390 No abstract available.

2

Teriflunomide as a therapeutic means for myelin repair.

Göttle P, Groh J, Reiche L, Gruchot J, Rychlik N, Werner L, Samper Agrelo I, Akkermann R, Zink A, Prigione A, Hartung HP, Martini R, Küry P. Göttle P, et al. J Neuroinflammation. 2023 Jan 7;20(1):7. doi: 10.1186/s12974-022-02686-6. J Neuroinflammation. 2023. PMID: 36611185 Free PMC article.

3

Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?

Reiche L, Küry P, Göttle P. Reiche L, et al. Among authors: gottle p. Cells. 2019 Dec 7;8(12):1591. doi: 10.3390/cells8121591. Cells. 2019. PMID: 31817891 Free PMC article. Review.

4

Remyelination in multiple sclerosis: from concept to clinical trials.

Kremer D, Göttle P, Flores-Rivera J, Hartung HP, Küry P. Kremer D, et al. Among authors: gottle p. Curr Opin Neurol. 2019 Jun;32(3):378-384. doi: 10.1097/WCO.0000000000000692. Curr Opin Neurol. 2019. PMID: 30865009 Review.

5

The Molecular Basis for Remyelination Failure in Multiple Sclerosis.

Gruchot J, Weyers V, Göttle P, Förster M, Hartung HP, Küry P, Kremer D. Gruchot J, et al. Among authors: gottle p. Cells. 2019 Aug 3;8(8):825. doi: 10.3390/cells8080825. Cells. 2019. PMID: 31382620 Free PMC article. Review.

6

Multiple sclerosis drug repurposing for neuroregeneration.

Göttle P, Dietrich M, Küry P. Göttle P, et al. Neural Regen Res. 2024 Mar;19(3):507-508. doi: 10.4103/1673-5374.380901. Neural Regen Res. 2024. PMID: 37721276 Free PMC article. No abstract available.

7

A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage.

Werner L, Gliem M, Rychlik N, Pavic G, Reiche L, Kirchhoff F, Silva Oliveira Junior M, Gruchot J, Meuth SG, Küry P, Göttle P. Werner L, et al. Among authors: gottle p. Int J Mol Sci. 2023 Jun 30;24(13):10972. doi: 10.3390/ijms241310972. Int J Mol Sci. 2023. PMID: 37446147 Free PMC article.

8

An unmet clinical need: roads to remyelination in MS.

Göttle P, Förster M, Weyers V, Küry P, Rejdak K, Hartung HP, Kremer D. Göttle P, et al. Neurol Res Pract. 2019 Jul 8;1:21. doi: 10.1186/s42466-019-0026-0. eCollection 2019. Neurol Res Pract. 2019. PMID: 33324887 Free PMC article. Review.

9

A gene regulatory architecture that controls region-independent dynamics of oligodendrocyte differentiation.

Cantone M, Küspert M, Reiprich S, Lai X, Eberhardt M, Göttle P, Beyer F, Azim K, Küry P, Wegner M, Vera J. Cantone M, et al. Among authors: gottle p. Glia. 2019 May;67(5):825-843. doi: 10.1002/glia.23569. Epub 2019 Feb 7. Glia. 2019. PMID: 30730593 Review.

10

Pushing Forward: Remyelination as the New Frontier in CNS Diseases.

Kremer D, Göttle P, Hartung HP, Küry P. Kremer D, et al. Among authors: gottle p. Trends Neurosci. 2016 Apr;39(4):246-263. doi: 10.1016/j.tins.2016.02.004. Epub 2016 Mar 7. Trends Neurosci. 2016. PMID: 26964504 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year